M S HofmanSummaryAffiliation: Peter MacCallum Cancer Centre Country: Australia Publications
| Collaborators
|
Detail Information
Publications
Improving Diagnosis of Tumor-Induced Osteomalacia With Gallium-68 DOTATATE PET/CTRoderick J Clifton-Bligh
Centre for Cancer Imaging, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia
J Clin Endocrinol Metab 98:687-94. 2013..Serum phosphate should be measured routinely in patients with unexplained muscle weakness, bone pain, or stress fractures to allow earlier diagnosis of TIO...
High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumoursMichael S Hofman
Centre for Cancer Imaging, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia
J Med Imaging Radiat Oncol 56:40-7. 2012..This study assesses the management impact of incremental diagnostic information obtained from this technique compared with conventional staging...
Imaging in follicular NHLM S Hofman
Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
Best Pract Res Clin Haematol 24:165-77. 2011..Molecular imaging is likely to play an increasing role in selection of patients for specific treatments and in prognostic stratification...
68Ga PET/CT ventilation-perfusion imaging for pulmonary embolism: a pilot study with comparison to conventional scintigraphyMichael S Hofman
Molecular Imaging, Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
J Nucl Med 52:1513-9. 2011..This pilot study assessed the feasibility of performing V/Q PET/CT and compared diagnostic utility with conventional V/Q imaging in patients with clinical suspicion of PE...
White fat, factitious hyperglycemia, and the role of FDG PET to enhance understanding of adipocyte metabolismMichael S Hofman
Center for Cancer Imaging, Peter MacCallum Cancer Centre, St, Andrews Place, East Melbourne, VIC 3002 Australia
EJNMMI Res 1:2. 2011..We discuss the potential biological basis of this finding and provide recommendations on the avoidance of this complication...
The potential for induction peptide receptor chemoradionuclide therapy to render inoperable pancreatic and duodenal neuroendocrine tumours resectableT W Barber
Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria 3002, Australia
Eur J Surg Oncol 38:64-71. 2012....
